148 related articles for article (PubMed ID: 34665662)
1. Identifying Individualized Risk Profiles for Radiotherapy-Induced Lymphopenia Among Patients With Esophageal Cancer Using Machine Learning.
Zhu C; Mohan R; Lin SH; Jun G; Yaseen A; Jiang X; Wang Q; Cao W; Hobbs BP
JCO Clin Cancer Inform; 2021 Sep; 5():1044-1053. PubMed ID: 34665662
[TBL] [Abstract][Full Text] [Related]
2. Personalized Composite Dosimetric Score-Based Machine Learning Model of Severe Radiation-Induced Lymphopenia Among Patients With Esophageal Cancer.
Chu Y; Zhu C; Hobbs BP; Chen Y; van Rossum PSN; Grassberger C; Zhi D; Lin SH; Mohan R
Int J Radiat Oncol Biol Phys; 2024 May; ():. PubMed ID: 38797500
[TBL] [Abstract][Full Text] [Related]
3. CT-based dosiomics and radiomics model predicts radiation-induced lymphopenia in nasopharyngeal carcinoma patients.
Huang Q; Yang C; Pang J; Zeng B; Yang P; Zhou R; Wu H; Shen L; Zhang R; Lou F; Jin Y; Abdilim A; Jin H; Zhang Z; Xie X
Front Oncol; 2023; 13():1168995. PubMed ID: 37954080
[TBL] [Abstract][Full Text] [Related]
4. Prediction of Severe Lymphopenia During Chemoradiation Therapy for Esophageal Cancer: Development and Validation of a Pretreatment Nomogram.
van Rossum PSN; Deng W; Routman DM; Liu AY; Xu C; Shiraishi Y; Peters M; Merrell KW; Hallemeier CL; Mohan R; Lin SH
Pract Radiat Oncol; 2020; 10(1):e16-e26. PubMed ID: 31369887
[TBL] [Abstract][Full Text] [Related]
5. Severe lymphopenia during neoadjuvant chemoradiation for esophageal cancer: A propensity matched analysis of the relative risk of proton versus photon-based radiation therapy.
Shiraishi Y; Fang P; Xu C; Song J; Krishnan S; Koay EJ; Mehran RJ; Hofstetter WL; Blum-Murphy M; Ajani JA; Komaki R; Minsky B; Mohan R; Hsu CC; Hobbs BP; Lin SH
Radiother Oncol; 2018 Jul; 128(1):154-160. PubMed ID: 29248170
[TBL] [Abstract][Full Text] [Related]
6. Intensity-modulated proton therapy further reduces normal tissue exposure during definitive therapy for locally advanced distal esophageal tumors: a dosimetric study.
Welsh J; Gomez D; Palmer MB; Riley BA; Mayankkumar AV; Komaki R; Dong L; Zhu XR; Likhacheva A; Liao Z; Hofstetter WL; Ajani JA; Cox JD
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1336-42. PubMed ID: 21470796
[TBL] [Abstract][Full Text] [Related]
7. Proton therapy reduces the likelihood of high-grade radiation-induced lymphopenia in glioblastoma patients: phase II randomized study of protons vs photons.
Mohan R; Liu AY; Brown PD; Mahajan A; Dinh J; Chung C; McAvoy S; McAleer MF; Lin SH; Li J; Ghia AJ; Zhu C; Sulman EP; de Groot JF; Heimberger AB; McGovern SL; Grassberger C; Shih H; Ellsworth S; Grosshans DR
Neuro Oncol; 2021 Feb; 23(2):284-294. PubMed ID: 32750703
[TBL] [Abstract][Full Text] [Related]
8. Spleen Dose-Volume Parameters as a Predictor of Treatment-related Lymphopenia During Definitive Chemoradiotherapy for Esophageal Cancer.
Saito T; Toya R; Yoshida N; Shono T; Matsuyama T; Ninomura S; Watakabe T; Sasaki Y; Baba H; Oya N
In Vivo; 2018; 32(6):1519-1525. PubMed ID: 30348711
[TBL] [Abstract][Full Text] [Related]
9. A novel deep learning model using dosimetric and clinical information for grade 4 radiotherapy-induced lymphopenia prediction.
Zhu C; Lin SH; Jiang X; Xiang Y; Belal Z; Jun G; Mohan R
Phys Med Biol; 2020 Feb; 65(3):035014. PubMed ID: 31851954
[TBL] [Abstract][Full Text] [Related]
10. Proton and Carbon Ion Radiation Therapy Decreased Severe Lymphopenia by Reducing Thoracic Vertebra and Aortic Doses in Non-Small Cell Lung Cancer Versus Intensity Modulated Radiation Therapy.
Li Y; Fan X; Yu Q; Zhai H; Mo M; Sun J; Mi J; Lu R; Mao J; Chen J; Ma N; Yang W; Zhu J; Jiang G; Wu K
Int J Radiat Oncol Biol Phys; 2023 Jul; 116(3):579-589. PubMed ID: 36586495
[TBL] [Abstract][Full Text] [Related]
11. Lymphopenia During Definitive Chemoradiotherapy in Esophageal Squamous Cell Carcinoma: Association with Dosimetric Parameters and Patient Outcomes.
Xu H; Lin M; Hu Y; Zhang L; Li Q; Zhu J; Wang S; Xi M
Oncologist; 2021 Mar; 26(3):e425-e434. PubMed ID: 32960471
[TBL] [Abstract][Full Text] [Related]
12. Proton beam therapy reduces the risk of severe radiation-induced lymphopenia during chemoradiotherapy for locally advanced non-small cell lung cancer: A comparative analysis of proton versus photon therapy.
Kim N; Myoung Noh J; Lee W; Park B; Park H; Young Park J; Pyo H
Radiother Oncol; 2021 Mar; 156():166-173. PubMed ID: 33359267
[TBL] [Abstract][Full Text] [Related]
13. Development of a risk prediction model for radiation dermatitis following proton radiotherapy in head and neck cancer using ensemble machine learning.
Lee TF; Liu YH; Chang CH; Chiu CL; Lin CH; Shao JC; Yen YC; Lin GZ; Yang J; Tseng CD; Fang FM; Chao PJ; Lee SH
Radiat Oncol; 2024 Jun; 19(1):78. PubMed ID: 38915112
[TBL] [Abstract][Full Text] [Related]
14. A machine learning model for grade 4 lymphopenia prediction during pelvic radiotherapy in patients with cervical cancer.
Xu Z; Yang L; Yu H; Guo L
Front Oncol; 2022; 12():905222. PubMed ID: 36185193
[TBL] [Abstract][Full Text] [Related]
15. Normal Tissue Injury Induced by Photon and Proton Therapies: Gaps and Opportunities.
Prasanna PG; Rawojc K; Guha C; Buchsbaum JC; Miszczyk JU; Coleman CN
Int J Radiat Oncol Biol Phys; 2021 Aug; 110(5):1325-1340. PubMed ID: 33640423
[TBL] [Abstract][Full Text] [Related]
16. Severe Lymphopenia During Chemoradiation Therapy for Esophageal Cancer: Comprehensive Analysis of Randomized Phase 2B Trial of Proton Beam Therapy Versus Intensity Modulated Radiation Therapy.
Wang X; van Rossum PSN; Chu Y; Hobbs BP; Grassberger C; Hong TS; Liao Z; Yang J; Zhang X; Netherton T; Mohan R; Lin SH
Int J Radiat Oncol Biol Phys; 2024 Feb; 118(2):368-377. PubMed ID: 37652304
[TBL] [Abstract][Full Text] [Related]
17. Potential Determinants for Radiation-Induced Lymphopenia in Patients With Breast Cancer Using Interpretable Machine Learning Approach.
Yu H; Chen F; Lam KO; Yang L; Wang Y; Jin JY; Ei Helali A; Kong FS
Front Immunol; 2022; 13():768811. PubMed ID: 35799797
[TBL] [Abstract][Full Text] [Related]
18. Lymphocyte Nadir and Esophageal Cancer Survival Outcomes After Chemoradiation Therapy.
Davuluri R; Jiang W; Fang P; Xu C; Komaki R; Gomez DR; Welsh J; Cox JD; Crane CH; Hsu CC; Lin SH
Int J Radiat Oncol Biol Phys; 2017 Sep; 99(1):128-135. PubMed ID: 28816138
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and Safety in Proton Therapy and Photon Therapy for Patients With Esophageal Cancer: A Meta-Analysis.
Zhou P; Du Y; Zhang Y; Zhu M; Li T; Tian W; Wu T; Xiao Z
JAMA Netw Open; 2023 Aug; 6(8):e2328136. PubMed ID: 37581887
[TBL] [Abstract][Full Text] [Related]
20. Proton beam therapy can achieve lower vertebral bone marrow dose than photon beam therapy during chemoradiation therapy of esophageal cancer.
Zhang Y; Jabbour SK; Zhang A; Liu B; Yue NJ; Biswal NC
Med Dosim; 2021 Autumn; 46(3):229-235. PubMed ID: 33454170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
